Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy

Published:2024-02 Issue: Volume:265 Page:116054
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Xinxin,Wang Cheng,Li Shang,Yin Fucheng,Luo Heng,Zhang Yonglei,Luo Zhongwen,Chen Yifan,Wan Siyuan,Kong Lingyi,Wang Xiaobing^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference38 articles.

1. Subtyping of triple-negative breast cancer: implications for therapy;Abramson;Cancer,2015

2. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes;Buys;Cancer,2017

3. Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes;Lehmann;Nat. Commun.,2021

4. BRCA1 mutations in cancer: coordinating deficiencies in homologous recombination with tumorigenesis;Krais;Cancer Res.,2020

5. BRCAness, homologous recombination deficiencies, and synthetic lethality;Murai;Cancer Res.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer;Frontiers in Oncology;2024-08-02

2. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry;Future Medicinal Chemistry;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP